Dr. O'Sullivan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st Street SW
Rochester, MN 55905- Is this information wrong?
Education & Training
- University College of Dublin National Univ SOMClass of 2005
Certifications & Licensure
- MN State Medical License 2016 - 2024
- DC State Medical License 2013 - 2016
Clinical Trials
- Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy Start of enrollment: 2017 Nov 13
- T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial Start of enrollment: 2021 Jan 06
Publications & Presentations
PubMed
- 5 citationsAlliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer.Ciara C. O’Sullivan, Karla V. Ballman, Linda M. McCall, Anuhya Kommalapati, Tyler Zemla, Anna Weiss, Melissa Mitchell, Victoria S. Blinder, Nadine Tung, William J. Irv...> ;Future Oncology. 2021 Oct 12
- 30 citationsRegional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care.Emanuele Garreffa, Ahmed Hamad, Ciara C. O’Sullivan, Antonious Z. Hazim, Joanne York, Shama Puri, Anne Turnbull, John F.R. Robertson, Matthew P. Goetz> ;European Journal of Cancer. 2021 Oct 11
- 6 citationsRandomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated ...Tufia C. Haddad, Jun He, Ciara C. O’Sullivan, Beiyun Chen, Donald W. Northfelt, Amylou C. Dueck, Karla V. Ballman, Kathleen S. Tenner, Hannah M. Linden, Joseph A. Spar...> ;Breast Cancer Research and Treatment. 2021 Apr 14
- Join now to see all
Press Mentions
- Adjuvant Trastuzumab Benefit Elucidated in Small HER2-Positive Breast CancerAugust 28th, 2015
Professional Memberships
- Member
Hospital Affiliations
- Mayo Clinic Hospital - RochesterRochester, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: